SynBioBeta Speaker

Celestine Schnugg

Boom Capital

Founding Managing Partner

Celestine "Cee Cee" Schnugg is a Silicon Valley venture capitalist and the Founding Managing Partner of Boom Capital, an early stage venture firm financing scientists and engineers. She is the first investor in Mammoth Biosciences, A-Alpha Bio, Fauna Bio, and Diligent Robotics, and early rounds of Swarm Technologies (acquired by SpaceX), Astra (NASDAQ: ASTR), Planet (NYSE: PL) Impulse Space, and Galileo Health. Prior to Boom, she was at Eric Schmidt's Innovation Endeavors. Prior to Innovation Endeavors, she helped build the sustainability program at Apple. She has led global innovation initiatives with NASA and the White House and is the creator of Curiosity Camp and National Day of Civic Hacking. Celestine is on the Investment Committee of the Goldhirsh Foundation and was an Innovation Advisor to British Airways. Driven by the belief that no child should bear the weight of an untreatable disease, Cee Cee founded Project Atlas, a foundation accelerating translational research for cancer interception and rare pediatric conditions. Through Rare Team 6, a multidisciplinary operative, she leads efforts to uncover the biological drivers of undiagnosed conditions and build disease-specific biobanks-harnessing the decade's most powerful technologies to cure the incurable by 2035. At Boom Capital, she not only invests inception capital but convenes a scientific society of the top 200 technologists of the 21st century.

Sessions Featuring

Celestine

This Year

Breakout Session

•

3:30 PM

-

4:15 PM

Human Health

When Patients Become Pioneers: Parents Driving the Search for Rare Disease Cures

When a child has a rare disease with no treatment or cure, some parents do far more than advocate: they learn the science, build networks, fund research, and help create entirely new paths to therapy. This panel brings together parents who have become active participants in the search for answers, not because they planned to, but because time left them no alternative. For a SynBioBeta audience of researchers, founders, and builders, this is a chance to hear directly from the people living on the receiving end of scientific progress — and scientific delay. It is also an invitation: if you are working on a tool, platform, or idea that could help, these families are ready to collaborate.

Featuring

Celestine Schnugg

Boom Capital

Founding Managing Partner

Miki Heller

Brain Repair Foundation

Co-founder

Breakout Session

•

3:30 PM

-

4:15 PM

Human Health

When Patients Become Pioneers: Parents Driving the Search for Rare Disease Cures

When a child has a rare disease with no treatment or cure, some parents do far more than advocate: they learn the science, build networks, fund research, and help create entirely new paths to therapy. This panel brings together parents who have become active participants in the search for answers, not because they planned to, but because time left them no alternative. For a SynBioBeta audience of researchers, founders, and builders, this is a chance to hear directly from the people living on the receiving end of scientific progress — and scientific delay. It is also an invitation: if you are working on a tool, platform, or idea that could help, these families are ready to collaborate.

Featuring

Celestine Schnugg

Boom Capital

Founding Managing Partner

Miki Heller

Brain Repair Foundation

Co-founder

Previous Speakers Include